GlassScriptPhysician profile
Morgan E Moran
NPI 1083213557
$1,467.11
in general payments reported to CMS, 2019-2025
13 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $607 · 2024: $423 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.49 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $465.99 | 2023-2025 | Veozah |
| Pfizer INC. | $177.60 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $173.56 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $166.94 | 2022-2023 | |
| Abbvie INC. | $103.72 | 2022-2023 | |
| Exact Sciences Corporation | $102.00 | 2023-2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $57.11 | 2023-2024 | Twirla |
| Mycovia Pharmaceuticals, INC. | $53.17 | 2023 | Vivjoa |
| Biogen, INC. | $51.13 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $45.83 | 2022 | |
| Exeltis, USA INC. | $31.86 | 2022 | |
| Axonics, INC. | $22.13 | 2023 | Bulkamid, Axonics |
| Myovant Sciences INC. | $16.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.